BAY 59-3074 is a drug which is a cannabinoid receptor partial agonist developed by Bayer AG. It has analgesic effects and is used in scientific research. It is orally active in animals and has modest affinity for both CB1 and CB2 receptors with Ki values of 48.3nM at CB1 and 45.5nM at CB2.
This page contains content from the copyrighted Wikipedia article "BAY 59-3074"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
